Viridian Therapeutics, Inc.\DE (VRDN) Non-Current Deffered Revenue (2021 - 2025)
Viridian Therapeutics, Inc.\DE (VRDN) posted Non-Current Deffered Revenue of $140,000 for Q2 2025, down 67.3% from $428,000 a year earlier and down 34.0% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Non-Current Deffered Revenue (2021 - 2025) Analysis & Trends
At the end of FY2024, Viridian Therapeutics, Inc.\DE's Non-Current Deffered Revenue came in at $284,000, down 50.4% from FY2023.
- Annual Non-Current Deffered Revenue has declined for three consecutive years, with a three-year compound annual growth rate of -37.2% (FY2021 to FY2024).
- In prior years, Viridian Therapeutics, Inc.\DE's Non-Current Deffered Revenue was $573,000 in FY2023 (-33.4%), $861,000 in FY2022 (-25.1%) and $1.15 million in FY2021.
- The Q2 2025 figure stands as the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2021.
- On a year-over-year basis, Non-Current Deffered Revenue has declined in each of the last 11 quarters, with an average decline of 45.2% over the last eight quarters.
- Across the past five years, year-over-year decline in Non-Current Deffered Revenue ran from 25.1% in Q4 2022 to 67.3% in Q2 2025.
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $212,000 (Q1 2025), $284,000 (Q4 2024) and $356,000 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.53 Bn | -576.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 140,000.00 |
| Mar 31, 2025 | 212,000.00 |
| Dec 31, 2024 | 284,000.00 |
| Sep 30, 2024 | 356,000.00 |
| Jun 30, 2024 | 428,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 573,000.00 |
| Sep 30, 2023 | 645,000.00 |
| Jun 30, 2023 | 717,000.00 |
| Mar 31, 2023 | 789,000.00 |
| Dec 31, 2022 | 861,000.00 |
| Sep 30, 2022 | 933,000.00 |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 1.15 Mn |
API Access
Viridian Therapeutics, Inc.\DE Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();